Epic Capital Health VC

Congratulations to our portfolio company, Think Research, on their $25M raise. This investment represents one of the largest of its kind for a Canadian Health Technology company. This round was led by Fidelity Canada and Kayne Partners.

Toronto-based Think Research raises $25-million from Canadian, U.S. Investors TORONTO, Oct. 30, 2018 /CNW/ - Think Research, a leading digital healthcare platform provider, today announced that the Company has successfully completed its planned capital raise of over $25 million. This investment represents one of the largest of its kind for a Canadian healthcare technology fir...

We believe AI diagnostics for cardiovascular disease CVD are one of the most valuable innovations in health tech. This is why we invested in A4Life, one of the leaders in CVD AI innovation.

Machine-learning will revolutionise cardiovascular healthcare Combining big data and machine-learning gives clinicians a greater chance than ever of combatting the cause of 1 in 3 deaths.

Earlier this month, our portfolio company Cyclica formalized a collaboration with Eurofarma. We are pleased to see the continued growth of or portfolio companies.

Eurofarma and Cyclica Collaborate to Drive Polypharmacology in Drug Discovery Through AI-Augmented Technologies Eurofarma and Cyclica are pleased to announce a multi-phase collaboration to advance drug discovery programs by driving insights into small molecule polypharmacology.

We are excited for our portfolio company, Synaptive Medical, and their new partnership with Stryker's Advance Guidance technology business.

Synaptive Medical Partners with Stryker’s Advanced Guidance Technologies Business - Synaptive Medical Companies announce co-marketing partnership for BrightMatter™ Plan at CNS Toronto, Canada (October 8, 2018) – Synaptive Medical and Stryker’s Advanced Guidance Technologies business (formerly known as Stryker’s Navigation business) today announced a strategic partnership in surgical planning...

Congratulations to our portfolio company Think Research. They recently launched an expansion to their innovative VirtualCare platform by introducing a French-language version.

www.thinkresearch.com

Congratulations to our portfolio company Analytics 4 Life. Follow the link to see their recent press release highlighting an upcoming scientific presentation to be shared at a major cardiology convention being held in San Diego this weekend:

Analytics 4 Life to Present at the Transcatheter Cardiovascular Therapeutics (TCT) 2018 Scientific Symposium Analytics 4 Life, a digital health company dedicated to improving existing diagnostic pathways, today announced that clinical data will be presented a

Epic’s portfolio company Thought Wire has been able to attract an impressive advisory board. As an investor we are excited to see them take steps in the right direction >>

New ThoughtWire Advisory Board Looks to Unlock Promise of IoT for Built Environments, Expand ThoughtWire’s Executive Network and Accelerate Growth (September 11th, 2018) ThoughtWire-Mappedin Partnership Provides IoT-Informed Mapping for Built Environments | Mappedin’s mapping and wayfinding technology has been integrated into ThoughtWire’s people-centered and process-driven commercial IoT applications

Our portfolio client, Exact Imaging, announces Health Canada approval for its FusionVu™ application for Micro-Ultrasound/MRI Fusion.

Exact Imaging Announces Health Canada Approval for its FusionVu™ Application for Micro-Ultrasound/MRI Fusion | Markets Insider ExactVu™ micro-ultrasound platform - - now with FusionVu - - enables the highest real-time resolution for targeted prostate imaging and biopsy TORONTO, Sept...

Congrats to Epic portfolio company Cellaegis in completing enrolment for this critical study sponsored by William Osler Health System.

CellAegis Announces Completion of Patient Enrollment in First North American Study for Innovative Heart Attack Therapy Using autoRIC® TORONTO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and cost-effective solutions for acute and chronic cardiovascular conditions, today announced completion of pa...